Share-based Payment Arrangement, Expense of Acutus Medical, Inc. from 30 Jun 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Acutus Medical, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Jun 2019 to 31 Dec 2024.
  • Acutus Medical, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2024 was $81,000, a 90% decline year-over-year.
  • Acutus Medical, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2024 was $1,264,000, a 122% decline year-over-year.
  • Acutus Medical, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1,264,000, a 122% decline from 2023.
  • Acutus Medical, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5,733,000, a 39% decline from 2022.
  • Acutus Medical, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $9,391,000, a 32% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Acutus Medical, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,264,000 $81,000 -$736,000 -90% 01 Oct 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
Q3 2024 $528,000 $128,000 -$1,150,000 -90% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $622,000 $49,000 -$1,685,000 -97% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $2,307,000 $1,522,000 -$3,426,000 -180% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $5,733,000 $817,000 -$1,077,000 -57% 01 Oct 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 $6,810,000 $1,278,000 -$606,000 -32% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $7,416,000 $1,734,000 -$847,000 -33% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $8,263,000 $1,904,000 -$1,128,000 -37% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $9,391,000 $1,894,000 -$1,597,000 -46% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $10,988,000 $1,884,000 -$1,693,000 -47% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 $12,681,000 $2,581,000 -$1,195,000 -32% 01 Apr 2022 30 Jun 2022 10-Q 07 Aug 2023 2023 Q2
Q1 2022 $13,876,000 $3,032,000 +$122,000 +4.2% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $13,754,000 $3,491,000 +$660,000 +23% 01 Oct 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
Q3 2021 $13,094,000 $3,577,000 -$2,797,000 -44% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $15,891,000 $3,776,000 +$2,619,000 +226% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $13,272,000 $2,910,000 +$1,169,000 +67% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $12,103,000 $2,831,000 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $6,374,000 +$5,562,000 +685% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $1,157,000 +$354,000 +44% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $1,741,000 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q3 2019 $812,000 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2020 Q3
Q2 2019 $803,000 01 Apr 2019 30 Jun 2019 10-Q 18 Sep 2020 2020 Q2

Acutus Medical, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,264,000 -$6,997,000 -122% 01 Jan 2024 31 Dec 2024 10-K 24 Mar 2025 2024 FY
2023 $5,733,000 -$3,658,000 -39% 01 Jan 2023 31 Dec 2023 10-K 24 Mar 2025 2024 FY
2022 $9,391,000 -$4,363,000 -32% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $13,754,000 +$1,651,000 +14% 01 Jan 2021 31 Dec 2021 10-K 24 Mar 2023 2022 FY
2020 $12,103,000 +$9,109,000 +304% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $2,994,000 01 Jan 2019 31 Dec 2019 10-K 19 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.